Shorter peptides are advantageous as protein binders, as they offer high-affinity binding to a diverse set of targets and lower manufacturing costs, but their flexibility and limited structural data make them difficult to design. Here, the authors introduce EvoBind2, a method for designing novel linear and cyclic peptide binders of varying lengths using only the sequence of a target protein, without prior knowledge of binding sites or predefined binder lengths.
- Qiuzhen Li
- Efstathios Nikolaos Vlachos
- Patrick Bryant